Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 22, Issue 7, pp. 1642-1652
PubMed
Published By
Print ISSN
Online ISSN
History
- Received May 29, 2015
- Revision received October 16, 2015
- Accepted October 20, 2015
- Published first November 20, 2015.
Article Versions
- Previous version (November 20, 2015 - 09:14).
- Previous version (January 28, 2016 - 08:02).
- You are viewing the most recent version of this article.
Copyright & Usage
©2015 American Association for Cancer Research.
Author Information
- Laetitia E. Lamberts1,
- Catharina W. Menke-van der Houven van Oordt2,
- Eva J. ter Weele1,3,
- Frederike Bensch1,
- Michiel M. Smeenk1,
- Johannes Voortman2,
- Otto S. Hoekstra4,
- Simon P. Williams5,
- Bernard M. Fine6,
- Daniel Maslyar6,
- Johan R. de Jong7,
- Jourik A. Gietema1,
- Carolien P. Schröder1,
- Alphons H.H. Bongaerts8,
- Marjolijn N. Lub-de Hooge3,7,
- Henk M.W. Verheul2,
- Sandra M. Sanabria Bohorquez6,
- Andor W.J.M. Glaudemans7, and
- Elisabeth G.E. de Vries1,*
- 1Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
- 2Department of Medical Oncology, VU University Medical Center, Amsterdam, the Netherlands.
- 3Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
- 4Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, the Netherlands.
- 5Department of Early Clinical Development, Genentech, Inc. South San Francisco, California.
- 6Department of Biomedical Imaging, Genentech, Inc. South San Francisco, California.
- 7Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
- 8Department of Radiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
- ↵*Corresponding Author:
Elisabeth G.E. de Vries, Department of Medical Oncology, University Medical Center Groningen, PO Box 30.001, Groningen 9700 RB, the Netherlands. Phone: 0031-50-3612821; Fax: 0031-50-3614862; E-mail: e.g.e.de.vries{at}umcg.nl
April 2016
Volume 22, Issue 7
Volume 22, Issue 7
ImmunoPET with Anti-Mesothelin Antibody in Patients with Pancreatic and Ovarian Cancer before Anti-Mesothelin Antibody–Drug Conjugate Treatment
Jump to section
Advertisement